Partnership for Safe Medicines Commends New Anti-Counterfeiting Agreement

October 25, 2007

WASHINGTON, D.C. (Oct. 24, 2007) — The Partnership for Safe Medicines commends yesterday's announcement by the U.S. Trade Representative of a new six-country Anti-Counterfeiting Trade Agreement (ACTA). The purpose of ACTA is to step up enforcement efforts against international counterfeiters.